Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 2 |
Descriptor
Behavior Disorders | 6 |
Program Effectiveness | 6 |
Children | 5 |
Adults | 4 |
Drug Therapy | 4 |
Outcomes of Treatment | 4 |
Pervasive Developmental… | 4 |
Behavior Modification | 3 |
Behavior Problems | 3 |
Emotional Disturbances | 3 |
Aggression | 2 |
More ▼ |
Source
Journal of Autism and… | 6 |
Author
Publication Type
Journal Articles | 6 |
Reports - Research | 3 |
Opinion Papers | 2 |
Information Analyses | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Aberrant Behavior Checklist | 1 |
What Works Clearinghouse Rating
Call, Nathan A.; Simmons, Christina A.; Mevers, Joanna E.; Alvarez, Jessica P. – Journal of Autism and Developmental Disorders, 2015
Pica is a potentially deadly form of self-injurious behavior most frequently exhibited by individuals with developmental and intellectual disabilities. Research indicates that pica can be decreased with behavioral interventions; however, the existing literature reflects treatment effects for small samples (n = 1-4) and the overall success of such…
Descriptors: Self Destructive Behavior, Developmental Disabilities, Mental Retardation, Behavior Disorders
Bearss, Karen; Johnson, Cynthia; Handen, Benjamin; Smith, Tristram; Scahill, Lawrence – Journal of Autism and Developmental Disorders, 2013
Guidance on effective interventions for disruptive behavior in young children with autism spectrum disorders (ASDs) is limited. We present feasibility and initial efficacy data on a structured parent training program for 16 children (ages 3-6) with ASD and disruptive behavior. The 6-month intervention included 11 Core and up to 2 Optional…
Descriptors: Parents, Autism, Young Children, Parent Education

Horrigan, Joseph P.; Barnhill, L. Jarrett – Journal of Autism and Developmental Disorders, 1997
In this study, 11 males with autism and mental retardation were administered risperidone. Substantial clinical improvement was noted almost immediately; patients with aggression, self-injury, explosivity, and poor sleep hygiene were most improved. The modal dose for optimal response was 0.5 mg bid. Weight gain was a significant side effect.…
Descriptors: Adults, Aggression, Autism, Behavior Disorders

McDougle, Christopher J.; Kresch, Laura E.; Posey, David J. – Journal of Autism and Developmental Disorders, 2000
Results from two studies indicate the nonselective serotonin reuptake inhibitor (SRI) clomipramine is more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in children with autism. A study of the selective SRI fluvoxamine found it to be significantly better than placebo for reducing repetitive…
Descriptors: Adults, Behavior Disorders, Behavior Problems, Children

Gordon, C. T. – Journal of Autism and Developmental Disorders, 2000
This commentary discusses study results that indicate the nonselective serotonin reuptake inhibitor (SRI) clomipramine is more efficacious than the relatively selective norepinephrine reuptake inhibitor desipramine and placebo in treating repetitive or ritualized behaviors in children with autism. The need for concurrent genetic and biochemical…
Descriptors: Adults, Behavior Disorders, Behavior Problems, Children

King, Bryan H. – Journal of Autism and Developmental Disorders, 2000
This article reviews the psychopharmacological treatment of aggression, mood disturbances, and self-injurious behavior in persons with autistic disorder. It highlights the use of dopaminergic drugs, serotonergic drugs, opioidergic drugs, adrenergic drugs, thymoleptic drugs, and glutamatergic drugs for their potential utility in treating…
Descriptors: Adults, Aggression, Behavior Disorders, Behavior Problems